Ken‐ichi Kusakabe

1.0k total citations
21 papers, 536 citations indexed

About

Ken‐ichi Kusakabe is a scholar working on Molecular Biology, Physiology and Computational Theory and Mathematics. According to data from OpenAlex, Ken‐ichi Kusakabe has authored 21 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Ken‐ichi Kusakabe's work include Alzheimer's disease research and treatments (6 papers), Computational Drug Discovery Methods (6 papers) and Catalysts for Methane Reforming (3 papers). Ken‐ichi Kusakabe is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Computational Drug Discovery Methods (6 papers) and Catalysts for Methane Reforming (3 papers). Ken‐ichi Kusakabe collaborates with scholars based in Japan, Belgium and United States. Ken‐ichi Kusakabe's co-authors include Shu̅ Kobayashi, Haruro Ishitani, Kenji Asami, Yasuo Ohtsuka, Susumu Komiyama, Yoshiyuki Nishiyama, Harrie J. M. Gijsen, Frederik Rombouts, Ryuji Miura and Momoji Kubo and has published in prestigious journals such as Langmuir, Journal of Medicinal Chemistry and International Journal of Hydrogen Energy.

In The Last Decade

Ken‐ichi Kusakabe

20 papers receiving 521 citations

Peers

Countries citing papers authored by Ken‐ichi Kusakabe

Since Specialization

Citations

This map shows the geographic impact of Ken‐ichi Kusakabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichi Kusakabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichi Kusakabe more than expected).

Fields of papers citing papers by Ken‐ichi Kusakabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐ichi Kusakabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichi Kusakabe. The network helps show where Ken‐ichi Kusakabe may publish in the future.

Co-authorship network of co-authors of Ken‐ichi Kusakabe

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichi Kusakabe. A scholar is included among the top collaborators of Ken‐ichi Kusakabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichi Kusakabe. Ken‐ichi Kusakabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Foreword 2024 ·Chemical and Pharmaceutical Bulletin ·Ken‐ichi Kusakabe	0
2	Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer’s Disease: Recent Advances and Perspectives 2024 ·Chemical and Pharmaceutical Bulletin ·Naoyuki Suzuki, (unknown), (unknown), Ken‐ichi Kusakabe	16
3	Dual 5-HT_2A and 5-HT_2C Receptor Inverse Agonist That Affords In Vivo Antipsychotic Efficacy with Minimal hERG Inhibition for the Treatment of Dementia-Related Psychosis 2024 ·Journal of Medicinal Chemistry ·Takuya Oguma, (unknown), Kenji Nakahara, Hidetsugu Asada, (unknown), (unknown), (unknown), (unknown), Nozomi Takai, Ken Koda, Sayaka Fujita, Yusuke Sekiguchi, (unknown), (unknown), (unknown), (unknown), (unknown), So Iwata, Ken‐ichi Kusakabe	3
4	Origin of the kinetic HDAC2‐selectivity of an HDAC inhibitor 2023 ·Journal of Computational Chemistry ·(unknown), Yukihiro Itoh, Takashi Kurohara, Takayoshi Suzuki, (unknown), Ken‐ichi Kusakabe, Yuko Okamoto	3
5	A Quantum Mechanics-Based Method to Predict Intramolecular Hydrogen Bond Formation Reflecting P-glycoprotein Recognition 2023 ·ACS Medicinal Chemistry Letters ·Takuya Oguma, Shota Uehara, Kenji Nakahara, (unknown), (unknown), Naoyuki Suzuki, Yukiko Kan, (unknown), (unknown), Ken‐ichi Kusakabe	1
6	Balancing potency and basicity by incorporating fluoropyridine moieties: Discovery of a 1-amino-3,4-dihydro-2,6-naphthyridine BACE1 inhibitor that affords robust and sustained central Aβ reduction 2021 ·European Journal of Medicinal Chemistry ·Kenji Nakahara, (unknown), (unknown), Takahiko Yamamoto, Shiho Yamamoto, Hisanori Ito, Yasuto Kido, Ken‐ichi Kusakabe	4
7	Discovery of Extremely Selective Fused Pyridine-Derived β-Site Amyloid Precursor Protein-Cleaving Enzyme (BACE1) Inhibitors with High In Vivo Efficacy through 10s Loop Interactions 2021 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Shiho Yamamoto, (unknown), (unknown), Hisanori Ito, Diederik Moechars, Frederik Rombouts, Harrie J. M. Gijsen, Ken‐ichi Kusakabe	10
8	Facile Construction of an Amino-1,3-Oxazine Scaffold using Burgess Reagent Under Mild Conditions 2020 ·Tetrahedron Letters ·(unknown), Moriyasu Masui, (unknown), Ken‐ichi Kusakabe	1
9	Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020) 2020 ·Expert Opinion on Therapeutic Patents ·Frederik Rombouts, Ken‐ichi Kusakabe, Chien‐Chi Hsiao, Harrie J. M. Gijsen	20
10	Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2 2019 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Takahiko Yamamoto, Kenji Nakahara, (unknown), Hisanori Ito, (unknown), Diederik Moechars, Harrie J. M. Gijsen, Ken‐ichi Kusakabe	27
11	Synthesis of a 6-CF₃-Substituted 2-Amino-dihydro-1,3-thiazine β-Secretase Inhibitor by N,N-Diethylaminosulfur Trifluoride-Mediated Chemoselective Cyclization 2018 ·The Journal of Organic Chemistry ·Takuya Oguma, (unknown), Shinji Suzuki, (unknown), (unknown), Masayoshi Ogawa, Ken‐ichi Kusakabe	8
12	Selective CB2 agonists with anti-pruritic activity: Discovery of potent and orally available bicyclic 2-pyridones 2013 ·Bioorganic & Medicinal Chemistry ·Ken‐ichi Kusakabe, Yasuyoshi Iso, Yukio Tada, Masahiro Sakagami, Yasuhide Morioka, (unknown), (unknown), Keiko Kawamoto, Hideyuki Takenaka, Kiyoshi Yasui, Hiroshi Hamana, Kohji Hanasaki	16
13	Design, synthesis, and binding mode prediction of 2-pyridone-based selective CB2 receptor agonists 2013 ·Bioorganic & Medicinal Chemistry ·Ken‐ichi Kusakabe, Yukio Tada, Yasuyoshi Iso, Masahiro Sakagami, Yasuhide Morioka, (unknown), (unknown), Keiko Kawamoto, Hideyuki Takenaka, Kiyoshi Yasui, Hiroshi Hamana, Kohji Hanasaki	33
14	Hydrogen production in zirconia membrane reactors for use in PEM fuel cells 2005 ·International Journal of Hydrogen Energy ·Ken‐ichi Kusakabe, (unknown), (unknown), Masaaki Oda, Ken‐Ichiro Sotowa	20
15	Chiral Catalyst Optimization Using Both Solid-Phase and Liquid-Phase Methods in Asymmetric Aza Diels−Alder Reactions 2000 ·Organic Letters ·Shu̅ Kobayashi, Ken‐ichi Kusakabe, Haruro Ishitani	73
16	Molecular Dynamics Simulation of Friction of Hydrocarbon Thin Films 1999 ·Langmuir ·Hiroyuki Tamura, (unknown), Ken‐ichi Kusakabe, (unknown), Ryuji Miura, Momoji Kubo, Kazuo Teraishi, Abhijit Chatterjee, Akira Miyamoto	44
17	A Switch of Enantiofacial Selectivities Using Designed Similar Chiral Ligands in Zirconium-Catalyzed Asymmetric Aza Diels−Alder Reactions 1999 ·The Journal of Organic Chemistry ·Shu̅ Kobayashi, Ken‐ichi Kusakabe, Susumu Komiyama, Haruro Ishitani	97
18	Synthesis of ethane and ethylene from methane and carbon dioxide over praseodymium oxide catalysts 1997 ·Applied Catalysis A General ·Kenji Asami, Ken‐ichi Kusakabe, (unknown), Yasuo Ohtsuka	74
19	Conversion of methane with carbon dioxide into C2 hydrocarbons over metal oxides 1995 ·Applied Catalysis A General ·Kenji Asami, (unknown), Ken‐ichi Kusakabe, Yoshiyuki Nishiyama, Yasuo Ohtsuka	54
20	Preparation and characterization of reactively sputtered SiCxNy films 1990 ·Thin Solid Films ·(unknown), Yuko HIROHATA, Shin Fukuda, Tomoaki Hino, T. Yamashina, (unknown), Ken‐ichi Kusakabe	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact